These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1616664)

  • 21. Current approaches to vaccination against human immunodeficiency viruses.
    Gluckman JC; Yagello M; Bahraoui E; Girard M
    Allergol Immunopathol (Madr); 1991; 19(1):11-3. PubMed ID: 1719790
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1.
    Schindler M; Münch J; Kutsch O; Li H; Santiago ML; Bibollet-Ruche F; Müller-Trutwin MC; Novembre FJ; Peeters M; Courgnaud V; Bailes E; Roques P; Sodora DL; Silvestri G; Sharp PM; Hahn BH; Kirchhoff F
    Cell; 2006 Jun; 125(6):1055-67. PubMed ID: 16777597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcloning of HIV-2 nef genes in E. coli and immunological reactivity of expressed fusion proteins.
    Ulrich R; Siakkou H; Mayer J; Kienzle N; Müller-Lantzsch N; Krüger DH
    Virus Genes; 1993 Sep; 7(3):229-40. PubMed ID: 8279123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological detection of attenuated HIV-1 variants with nef gene deletions.
    Greenway AL; Mills J; Rhodes D; Deacon NJ; McPhee DA
    AIDS; 1998 Apr; 12(6):555-61. PubMed ID: 9583594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological study of the nef protein from HIV-1 by polyclonal and monoclonal antibodies.
    Kienzle N; Bröker M; Harthus HP; Enders M; Erfle V; Buck M; Müller-Lantzsch N
    Arch Virol; 1991; 118(1-2):29-41. PubMed ID: 2048974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is anti-p27nef a useful diagnostic and prognostic marker in HIV-1 infection?
    Marty L; Laperche S; Bouchardeau F; Faucher V; Lefrere JJ; Couroucé AM
    AIDS; 1990 Nov; 4(11):1170-1. PubMed ID: 2282200
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV excretion patterns and specific antibody responses in body fluids.
    O'Shea S; Cordery M; Barrett WY; Richman DD; Bradbeer C; Banatvala JE
    J Med Virol; 1990 Aug; 31(4):291-6. PubMed ID: 2125310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients.
    Sabatier JM; Clerget-Raslain B; Fontan G; Fenouillet E; Rochat H; Granier C; Gluckman JC; Van Rietschoten J; Montagnier L; Bahraoui E
    AIDS; 1989 Apr; 3(4):215-20. PubMed ID: 2500954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The downside of success: confirmation of HIV infection in early treated children.
    Sutcliffe CG; Moss WJ
    Lancet Infect Dis; 2015 Jul; 15(7):751-2. PubMed ID: 26043883
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of HIV-2 antibodies using five commercial HIV enzyme immunoassays.
    Peeters M; Delaporte E; Dazza MC; Brun-Vézinet F
    AIDS; 1988 Oct; 2(5):389-90. PubMed ID: 3146269
    [No Abstract]   [Full Text] [Related]  

  • 32. Infection with HIV-2 in a resident of the United States.
    Popovsky MA; Carneski A; Hoff R; Fang CT; Krieger M
    N Engl J Med; 1990 Jun; 322(26):1887. PubMed ID: 2348844
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel, sensitive radioimmunoprecipitation assay for the detection of antibodies to human immunodeficiency virus-type 2.
    Selvam MP; Mayner RE; Buck SM; Epstein JS
    J Virol Methods; 1993 Sep; 44(1):1-10. PubMed ID: 8227273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective analysis of the prevalence of HIV seropositivity and its demographics in the normal healthy volunteer population of a phase-I clinical drug study unit.
    Jagathesan R; Lewis LD; Mant TG
    Br J Clin Pharmacol; 1995 Apr; 39(4):463-4. PubMed ID: 7640158
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infection.
    Schwander S; Braun RW; Kühn JE; Hufert FT; Kern P; Dietrich M; Wieland U
    J Med Virol; 1992 Feb; 36(2):142-6. PubMed ID: 1583468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EMAPII: A Key Player in HIV-Nef-induced Pulmonary Vasculopathy.
    Shamskhou EA; Verghese L; Yuan K; de Jesus Perez VA
    Am J Respir Cell Mol Biol; 2019 Mar; 60(3):257-258. PubMed ID: 30376353
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV antibodies--not virus--in immune globulins.
    Bond G; Loewen R
    Am J Nurs; 1988 Jun; 88(6):794. PubMed ID: 3163895
    [No Abstract]   [Full Text] [Related]  

  • 38. B-cell epitopes of the Nef protein.
    Spohn R; Gombert FO; Jung G
    Res Virol; 1992; 143(1):70-2. PubMed ID: 1373514
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV testing: promote a rational approach..
    Woods BJ
    Nurs Manage; 1992 Jan; 23(1):12. PubMed ID: 1731254
    [No Abstract]   [Full Text] [Related]  

  • 40. Serological markers during an acute HIV-2 infection.
    Ritter J; Chevallier P; Peyramond D; Sepetjan M
    Vox Sang; 1990; 59(4):244-5. PubMed ID: 2293463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.